Jack Pasini
Director/Board Member at Oligomerix, Inc.
Jack Pasini active positions
| Companies | Position | Start | End |
|---|---|---|---|
Oligomerix, Inc.
 Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Director/Board Member | 17/10/2010 | - |
| Corporate Officer/Principal | 13/10/2010 | - |
Career history of Jack Pasini
Former positions of Jack Pasini
| Companies | Position | Start | End |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Training of Jack Pasini
| Merrimack College | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Retail Trade | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Oligomerix, Inc.
Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Retail Trade |
- Stock Market
- Insiders
- Jack Pasini
- Experience
